Y Yin
1 Papers
Y Yin is an academic researcher. The author has contributed to research in topics: Cancer & Internal medicine. The author has co-authored 1 publications.
Chat about Author
Papers
79P Efficacy and safety of zimberelimab (GLS-010) monotherapy in patients with recurrent or metastatic cervical cancer: A multicenter, open-label, single-arm, phase II study
X Wu,Liming Xia,J. Wang,C. Wang,Q. Zhang,J. Zhu,Qian Wen Rao,H. Cheng,Z. Liu,Y Yin,Xin Lei Ai,Kurban Gulina,H. S. Zheng,X. Luo,B Chang,L. Li,H. Liu,Y. Li +17 more
TL;DR: Zimberelimab as discussed by the authors is a fully human anti-PD-1 monoclonal antibody with high affinity and selectivity for PD-1, which has been shown to be effective in patients with programmed death ligand-1-positive recurrent or metastatic cervical cancer.